Howard G. Welgus Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

ARQT Quotes by TradingView

Howard G. Welgus is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 69,744 shares of ARQT, which is worth approximately $1.74 Million. The most recent transaction as insider was on Feb 01, 2021, when has been sold 2,200 shares (Common Stock) at a price of $1.68 per share, resulting in proceeds of $3,696. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.7K
30.08% 3M change
54.1% 12M change
Total Value Held $1.74 Million

Howard G. Welgus Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 01 2021
BUY
Exercise of conversion of derivative security
$3,696 $1.68 p/Share
2,200 Added 1.17%
185,318 Common Stock
Jan 12 2021
BUY
Exercise of conversion of derivative security
$709 $0.58 p/Share
1,222 Added 0.66%
183,118 Common Stock
Jan 04 2021
SELL
Open market or private sale
$61,204 $27.82 p/Share
2,200 Reduced 1.2%
181,896 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$3,696 $1.68 p/Share
2,200 Added 1.18%
184,096 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$709 $0.58 p/Share
1,222 Added 0.67%
181,896 Common Stock
Dec 01 2020
SELL
Open market or private sale
$57,816 $26.28 p/Share
2,200 Reduced 1.21%
179,844 Common Stock
Dec 01 2020
BUY
Exercise of conversion of derivative security
$3,696 $1.68 p/Share
2,200 Added 1.19%
182,044 Common Stock
Nov 12 2020
BUY
Exercise of conversion of derivative security
$709 $0.58 p/Share
1,222 Added 0.67%
179,844 Common Stock
Nov 02 2020
SELL
Open market or private sale
$40,194 $18.27 p/Share
2,200 Reduced 1.22%
178,622 Common Stock
Nov 02 2020
BUY
Exercise of conversion of derivative security
$3,696 $1.68 p/Share
2,200 Added 1.2%
180,822 Common Stock
Oct 15 2020
BUY
Exercise of conversion of derivative security
$709 $0.58 p/Share
1,222 Added 0.68%
178,622 Common Stock
Oct 01 2020
SELL
Open market or private sale
$58,696 $26.68 p/Share
2,200 Reduced 1.22%
177,400 Common Stock
Oct 01 2020
BUY
Exercise of conversion of derivative security
$3,696 $1.68 p/Share
2,200 Added 1.22%
177,790 Common Stock
HGW

Howard G. Welgus

Director
Westlake Village, CA

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

News

Receive news related to Arcutis Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARQT